Jazz Pharmaceuticals Plc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jazz Pharmaceuticals Plc with three other
pharmaceutical manufacturers in Europe:
Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag
sales of 389.69 billion Hungarian Forints [US$1.47 billion]
of which 81%
was Pharmaceutical Manufacturing and Sale),
Krka DD Novo Mesto
(1.17 billion Euro [US$1.39 billion]
of which 63%
was European Union), and
Croda International Plc
based in the United Kingdom
(£1.24 billion [US$1.67 billion]
of which 34%
was Personal Care).
During the year ended December of 2016, sales at
Jazz Pharmaceuticals Plc were 1.35 billion Euro (US$1.59 billion).
increase of 12.2%
versus 2015, when the company's sales were 1.20 billion Euro.
This was the fifth consecutive year of sales increases at Jazz Pharmaceuticals Plc
(and since 2011, sales have increased a total of 592%).